BAAM
TECH icon

Baker Avenue Asset Management’s Bio-Techne TECH Stock Holding History

Baker Avenue Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,929
Closed -$205K – 859
2026
Q1 		$205K Sell
3,929
-2,280
-37% -$137K ﹤0.01% 723
2025
Q4 		$365K Buy
6,209
+108
+2% +$6.56K 0.01% 449
2025
Q3 		$339K Buy
+6,101
New +$327K 0.01% 448
2023
Q4 		– Sell
-14
Closed -$928 – 1369
2023
Q3 		$928 Sell
14
-10
-42% -$790 ﹤0.01% 1299
2023
Q2 		$1.96K Buy
+24
New +$1.93K ﹤0.01% 991
2023
Q1 		– Sell
-12
Closed -$995 – 1737
2022
Q4 		$995 Buy
+12
New +$953 ﹤0.01% 1101

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baker Avenue Asset Management's TECH Position: Q2 2026 in Review

Baker Avenue Asset Management sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 3,929 shares — an estimated $205K sold.

Baker Avenue Asset Management first reported a position in TECH in Q4 2022 and held it in 6 quarters. The position peaked at $365K in Q4 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Baker Avenue Asset Management reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Baker Avenue Asset Management sold 3,929 Bio-Techne shares in Q2 2026, an estimated $205K.
  • Baker Avenue Asset Management first reported a position in Bio-Techne in Q4 2022 and held it in 6 quarters.
  • Baker Avenue Asset Management's Bio-Techne position peaked at $365K in Q4 2025.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.